1Palucka K,Banchereau J. Cancer immunotherapy via dendritic cells[J].Nature Reviews Cancer,2012,(04):265-277.
2Jemal A,Bray F,Center MM. Global cancer statistics[J].CA:A Cancer Journal for Clinicians,2011,(02):69-90.
3Burgdorf SK. Dendritic cell vaccination of patients with metastatic colorectal cancers[J].Danish Medical Bulletin,2010,(09):B4171.
4VanCutsem E,Moiseyenko VM,Tjulandin S. Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line chemotherapy for advanced gastric cancer:a report of the V325 study group[J].Journal of Clinical Oncology,2006,(31):4991-4997.doi:10.1200/JCO.2006.06.8429.
5Frankenberger B,Schendel DJ. Third generation dendritic cell vaccines for tumor immunotherapy[J].European Journal of Cell Biology,2012,(01):53-58.
6Sadanga N,Nagashima H,Mashino K. Dendritic cell vaccination with MAGE peptide is a therapeutic approach for gastroin-testinal carcinomas[J].Clinical Cancer Research,2001,(08):2277-2284.
7Tanaka F,Haraguchi N,Isikawa K. Potential role of dendritic cell vaccination with MAGE peptides in gastrointestinal carcinomas[J].Oncology Reports,2008,(05):1111-1116.
8Kondo H,Hazama S,Kawaoka T. Aoptive immunotherapy for pancreatic cancer using Mucl peptidepulsed dendritic cells and activate T lymphocytes[J].Anticancer Research,2008,(1 B):379-387.
9Sakakibara M,Kanto T,Hayakawa M. Comprehensive immunological analyses of colorectal cancer patients in the phase Ⅰ/Ⅱ study of quickly matured dendritic cell vaccine vpulsed with carcinoembryonic antigen peptide[J].Cancer Immunology Immunotherapy,2011,(11):1565-1575.
10Toh HC,Wang WW,Chia WK. Clinical benefit of allogeneic melanoma cell lysate-pulsed autologous dendritic cell vaccine in MAGE-positive colorectal cancer patients[J].Clinical Cancer Research,2009,(24):7726-7736.
